Class information for:
Level 1: GLYPICAN 3//GPC3//SIMPSON GOLABI BEHMEL SYNDROME

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
18556 480 36.4 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
597 13382 HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//GLYPICAN 3

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GLYPICAN 3 Author keyword 196 76% 29% 138
2 GPC3 Author keyword 63 83% 7% 35
3 SIMPSON GOLABI BEHMEL SYNDROME Author keyword 42 69% 8% 36
4 GPC3 GENE Author keyword 14 100% 1% 7
5 GLYPICANS Author keyword 9 50% 3% 13
6 GLYPICAN Author keyword 8 25% 5% 26
7 PERLMAN SYNDROME Author keyword 7 53% 2% 10
8 GLYCOBIOL GRPBIOMED A13 Address 6 80% 1% 4
9 SIMPSON GOLABI BEHMEL SYNDROME SGBS Author keyword 6 100% 1% 4
10 GLYPICAN 3 GPC3 Author keyword 4 67% 1% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 GLYPICAN 3 196 76% 29% 138 Search GLYPICAN+3 Search GLYPICAN+3
2 GPC3 63 83% 7% 35 Search GPC3 Search GPC3
3 SIMPSON GOLABI BEHMEL SYNDROME 42 69% 8% 36 Search SIMPSON+GOLABI+BEHMEL+SYNDROME Search SIMPSON+GOLABI+BEHMEL+SYNDROME
4 GPC3 GENE 14 100% 1% 7 Search GPC3+GENE Search GPC3+GENE
5 GLYPICANS 9 50% 3% 13 Search GLYPICANS Search GLYPICANS
6 GLYPICAN 8 25% 5% 26 Search GLYPICAN Search GLYPICAN
7 PERLMAN SYNDROME 7 53% 2% 10 Search PERLMAN+SYNDROME Search PERLMAN+SYNDROME
8 SIMPSON GOLABI BEHMEL SYNDROME SGBS 6 100% 1% 4 Search SIMPSON+GOLABI+BEHMEL+SYNDROME+SGBS Search SIMPSON+GOLABI+BEHMEL+SYNDROME+SGBS
9 GLYPICAN 3 GPC3 4 67% 1% 4 Search GLYPICAN+3+GPC3 Search GLYPICAN+3+GPC3
10 OVERGROWTH SYNDROME 4 26% 3% 12 Search OVERGROWTH+SYNDROME Search OVERGROWTH+SYNDROME

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GPC3 93 86% 10% 48
2 OVERGROWTH SYNDROME 45 63% 9% 45
3 GOLABI BEHMEL SYNDROME 36 42% 14% 66
4 BEHMEL OVERGROWTH SYNDROME 32 69% 6% 27
5 GPC3 GENE 23 70% 4% 19
6 DEVELOPMENTALLY REGULATED TRANSCRIPT 15 68% 3% 13
7 DEPENDENT AUTOCLEAVAGE 15 77% 2% 10
8 GLYPICAN 3 EXPRESSION 14 40% 6% 27
9 CONTROLS CELLULAR RESPONSES 13 55% 3% 16
10 ONCOFETAL PROTEIN 12 53% 3% 16

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Glypican-3: A new target for cancer immunotherapy 2011 32 48 98%
Glypican-3 antibodies: A new therapeutic target for liver cancer 2014 7 54 81%
Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma 2013 19 48 69%
Glypicans 2008 156 44 57%
The role of glypicans in Hedgehog signaling 2014 10 59 32%
The role of glypicans in mammalian development 2002 69 59 51%
Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis 2014 1 34 71%
A 1 Mb-sized microdeletion Xq26.2 encompassing the GPC3 gene in a fetus with Simpson-Golabi-Behmel syndrome Report, antenatal findings and review 2011 2 17 88%
Gpc-3 is a Notable Diagnostic, Prognostic and a Latent Targeted Therapy Marker in Hepatocellular Carcinoma 2010 5 44 80%
Glypican-3: From the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma 2007 22 53 60%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GLYCOBIOL GRPBIOMED A13 6 80% 0.8% 4
2 SECT CANC IMMUNOTHER Y 4 46% 1.3% 6
3 EXPT MED SCIBIOMED A13 3 100% 0.6% 3
4 ANTIBODY THER Y SECT 3 60% 0.6% 3
5 GLYCOBIOL DEV GENET 2 25% 1.7% 8
6 SECT CELL MATRIX BIOL 2 25% 1.3% 6
7 BILLIARY TRACT SURG 2 1 100% 0.4% 2
8 BIOMED A13 1 40% 0.4% 2
9 HUMAN GENOME ANAL 1 22% 0.8% 4
10 OPERATING 1 21% 0.6% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000210608 SOTOS SYNDROME//WEAVER SYNDROME//CEREBRAL GIGANTISM
2 0.0000144997 SYNDECAN 1//SYNDECAN//SYNDECAN 4
3 0.0000144779 DES GAMMA CARBOXY PROTHROMBIN//GOLGI PROTEIN 73//GP73
4 0.0000102094 ADENOMATOUS HYPERPLASIA//MACROREGENERATIVE NODULES//LIVER CELL DYSPLASIA
5 0.0000092976 HEP PAR 1//NEEDLE TRACK SEEDING//HEPPAR 1
6 0.0000088949 HCCR 1//HUMAN CERVICAL CANCER ONCOGENE//HCCR
7 0.0000075733 MOUSE HEPATOCARCINOGENESIS//METABOLIC ZONATION//EXPT PATHOL EP
8 0.0000074034 CHD1L//CODON 249//SUPPRESSION OF TUMORIGENICITY
9 0.0000072394 HEPARAN SULFATE//OVERSULFATED CHONDROITIN SULFATE//HEPAROSAN
10 0.0000061677 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE